We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$7.57B
AUM Growth
+$643M
(+9.3%)
Cap. Flow
+$235M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$71M |
| 2 |
Baxter International
BAX
|
+$60.7M |
| 3 |
T-Mobile US
TMUS
|
+$60.1M |
| 4 |
Perrigo
PRGO
|
+$53.7M |
| 5 |
NRG Energy
NRG
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$68.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$53.3M |
| 3 |
Avient
AVNT
|
+$45.7M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$45.6M |
| 5 |
BHI
Baker Hughes
BHI
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.11% |
| 2 | Industrials | 11.84% |
| 3 | Consumer Discretionary | 11.65% |
| 4 | Technology | 10.61% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NPSP
726
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $249K | ﹤0.01% |
6,954
-9,261
| -57% | -$276K |
|
|
TLM
727
DELISTED
TALISMAN ENERGY INC
TLM
| $246K | ﹤0.01% |
+31,435
| New | +$198K |
|
728
Campbell Soup
CPB
$6.73B
| $245K | ﹤0.01% |
+5,578
| New | +$244K |
|
729
Flex
FLEX
$45.3B
| $241K | ﹤0.01% |
28,558
-21,863
| -43% | -$173K |
|
730
OneMain Financial
OMF
$7.48B
| $241K | ﹤0.01% |
+6,674
| New | +$242K |
|
731
Clean Harbors
CLH
$16.2B
| $239K | ﹤0.01% |
4,984
+2,561
| +106% | +$125K |
|
|
TPH
732
DELISTED
Tri Pointe Homes
TPH
| $234K | ﹤0.01% |
15,335
| – | – |
|
733
Sprouts Farmers Market
SFM
$8.13B
| $233K | ﹤0.01% |
+6,847
| New | +$209K |
|
|
ESPR
734
DELISTED
Esperion Therapeutics
ESPR
| $231K | ﹤0.01% |
+5,713
| New | +$175K |
|
735
Unum
UNM
$14.2B
| $222K | ﹤0.01% |
6,376
-7,131
| -53% | -$241K |
|
736
Designer Brands
DBI
$336M
| $221K | ﹤0.01% |
+5,933
| New | +$194K |
|
|
WIN
737
DELISTED
Windstream Holdings Inc
WIN
| $221K | ﹤0.01% |
3,429
+1,349
| +65% | +$103K |
|
738
Vale
VALE
$62.6B
| $216K | ﹤0.01% |
+26,358
| New | +$247K |
|
|
WLL
739
DELISTED
Whiting Petroleum Corporation
WLL
| $215K | ﹤0.01% |
22
-18
| -45% | -$275K |
|
|
CLGX
740
DELISTED
Corelogic, Inc.
CLGX
| $214K | ﹤0.01% |
6,784
| – | – |
|
|
AET
741
DELISTED
Aetna Inc
AET
| $211K | ﹤0.01% |
+2,371
| New | +$199K |
|
|
SNBR
742
DELISTED
Sleep Number
SNBR
| $209K | ﹤0.01% |
+7,727
| New | +$193K |
|
743
Chord Energy
CHRD
$7.46B
| $207K | ﹤0.01% |
12,490
+6,928
| +125% | +$172K |
|
744
First Solar
FSLR
$26.2B
| $205K | ﹤0.01% |
4,586
+274
| +6% | +$14K |
|
745
Pediatrix Medical
MD
$2.15B
| $205K | ﹤0.01% |
3,101
| – | – |
|
746
La-Z-Boy
LZB
$1.63B
| $203K | ﹤0.01% |
7,552
-5,175
| -41% | -$122K |
|
|
CZZ
747
DELISTED
Cosan Limited
CZZ
| $199K | ﹤0.01% |
+25,729
| New | +$237K |
|
748
Stellantis
STLA
$20.9B
| $195K | ﹤0.01% |
+25,835
| New | +$191K |
|
|
LOCK
749
DELISTED
LifeLock, Inc.
LOCK
| $189K | ﹤0.01% |
+10,208
| New | +$168K |
|
|
CMCM
750
Cheetah Mobile
CMCM
$101M
| $185K | ﹤0.01% |
+2,450
| New | +$213K |
|
Similar funds
Marshall Wace's Q4 2014 Portfolio in Review
As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.
- Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
- Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
- Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
- Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
- Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
- Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
- Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.
Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.